Published in Lancet on January 20, 1990
Normal 24-hour variation in a trial natriuretic peptide. Lancet (1989) 1.47
Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. J Acquir Immune Defic Syndr (2000) 1.78
Effects of self-management training in Type 2 diabetes: a randomized, prospective trial. Diabet Med (2007) 1.74
[Osteoporosis in patients under oral anticoagulant treatment. Concerning the article in DMW 50/2004]. Dtsch Med Wochenschr (2005) 1.39
Microscopy for symptomatic men: not all symptoms are born equal. Int J STD AIDS (2011) 1.38
Trends in attendances to genitourinary medicine services by older women. Int J STD AIDS (2012) 1.38
Reversible cognitive deterioration after a single episode of severe hypoglycaemia: a case report. Diabet Med (2004) 1.38
[Therapy of diabetes in adults using Glibornurid. Results and clinical studies]. Dtsch Med Wochenschr (1973) 1.38
Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med (2005) 1.21
Sexual behaviour, condom use, and disclosure of HIV status in HIV infected heterosexual individuals attending an inner London HIV clinic. Sex Transm Infect (2006) 1.20
Elevated endothelin-1 levels after cigarette smoking. Metabolism (1994) 1.09
Vertically acquired HIV diagnosed in adolescence and early adulthood in the United Kingdom and Ireland: findings from national surveillance. HIV Med (2009) 1.08
Gonorrhoea. Sex Transm Infect (2006) 1.07
Association of glucose levels and glucose variability with mood in type 1 diabetic patients. Diabetologia (2007) 1.04
Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Med (2013) 1.03
Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart (1996) 0.99
Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance. Diabetes Technol Ther (2006) 0.97
A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog. J Vet Pharmacol Ther (2001) 0.95
Epidemiology and immunogenetic background of islet cell antibody--positive nondiabetic schoolchildren. Ulm-Frankfurt population study. Diabetes (1991) 0.95
Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens (1992) 0.94
Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients. Diabetes Obes Metab (2007) 0.93
Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man. Diabetes Care (1987) 0.92
The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus. Curr Med Res Opin (2014) 0.91
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects. Diabetologia (1971) 0.89
Circulating endothelin in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg (1995) 0.86
Akathisia and metoclopramide. Lancet (1982) 0.86
Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med (2004) 0.86
Assessment of diabetes acceptance can help identify patients with ineffective diabetes self-care and poor diabetes control. Diabet Med (2014) 0.85
The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Exp Clin Endocrinol (1989) 0.85
[Compliance problems in therapy with levothyroxine]. Med Klin (Munich) (1990) 0.84
[Palatinite in type II diabetics. Effect on blood-glucose, serum-insulin, C-peptide and free fatty acids]. Dtsch Med Wochenschr (1982) 0.84
The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes. Diabetes Metab Res Rev (2007) 0.84
The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy. Microvasc Res (1999) 0.84
Influence of subchronic intake of melatonin at various times of the day on fatigue and hormonal levels: a placebo-controlled, double-blind trial. J Pineal Res (1989) 0.84
Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes (2000) 0.83
Would offering rapid point-of-care testing or non-invasive methods improve uptake of HIV testing among high-risk genitourinary medicine clinic attendees? A patient perspective. Int J STD AIDS (2008) 0.83
[On the regulation of nonesterified fatty acids with special reference to prostaglandins]. Dtsch Med Wochenschr (1966) 0.83
Classical and late-onset forms of congenital adrenal hyperplasia caused by 21-OH deficiency reveal different alterations in the C4/21-OH gene region. Mol Biol Med (1986) 0.82
Haemostasiological parameters as risk factor for new arterial occlusions in diabetics. Klin Wochenschr (1986) 0.81
Histometric investigations on the testicular tissue of rats with alloxan diabetes and Chinese hamsters with spontaneous diabetes. Acta Endocrinol (Copenh) (1967) 0.81
The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects. Arzneimittelforschung (1984) 0.81
Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study. J Cardiovasc Pharmacol (1987) 0.81
[Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]. Arzneimittelforschung (1974) 0.81
In vitro activity of biosynthetic human diarginylinsulin. Diabetologia (1990) 0.80
Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. J Vet Pharmacol Ther (2001) 0.80
[Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)]. Med Klin (1977) 0.80
In vivo evidence that human atrial natriuretic factor-(99-126) (hANF) stimulates parasympathetic activity in man. Eur J Clin Pharmacol (1990) 0.80
Effect of human atrial natriuretic peptide on blood glucose concentrations and hormone stimulation during insulin-induced hypoglycaemia in healthy man. Eur J Clin Pharmacol (1989) 0.80
The inhibiting effect of trilostane on adrenal steroid synthesis: hormonal and morphological alterations induced by subchronic trilostane treatment in normal rats. Res Exp Med (Berl) (1982) 0.80
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose. Diabetologia (1971) 0.79
[Diabetes mellitus and periodontitis. Bidirectional relationship and clinical implications. A consensus document]. Internist (Berl) (2011) 0.79
The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) (1999) 0.79
Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia. Atherosclerosis (2001) 0.79
[Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)]. Dtsch Med Wochenschr (1984) 0.79
Studies about unconjugated androstenediol in human peripheral plasma. J Clin Endocrinol Metab (1973) 0.79
Immunogenetic markers in patients with Graves' disease. Klin Wochenschr (1991) 0.79
Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty. Acta Endocrinol Suppl (Copenh) (1973) 0.79
Quantitative evaluation of an experimental inflammation induced with Freund's complete adjuvant in dogs. J Pharmacol Toxicol Methods (1994) 0.79
Emotional changes during experimentally induced hypoglycaemia in type 1 diabetes. Biol Psychol (2003) 0.78
Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry. Ger J Ophthalmol (1993) 0.78
Transplantation of human fetal pancreas: experience in thymusaplastic mice and rats and in a diabetic patient. Diabetes (1980) 0.78
Prevalence of fungal foot infections in patients with diabetes mellitus type 1 - underestimation of moccasin-type tinea. Exp Clin Endocrinol Diabetes (2004) 0.78
Melatonin and cortisol increase after fluvoxamine. Br J Clin Pharmacol (1986) 0.78
Elevated endothelin levels in patients with hyperlipoproteinemia. Clin Investig (1994) 0.78
Human fetal pancreas transplants in nu/nu mice. Lancet (1977) 0.78
[A new test-strip for checking blood-sugar levels]. Dtsch Med Wochenschr (1982) 0.78
[Etiology and prognosis of diabetic coma--a retrospective study]. Verh Dtsch Ges Inn Med (1971) 0.77
The impact of contralateral cooling on skin capillary blood cell velocity in patients with diabetes mellitus. J Vasc Res (1998) 0.77
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study. Int Angiol (1987) 0.77
Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue. Klin Wochenschr (1986) 0.77
[Determination of TSH receptor antibodies--clinical value]. Klin Wochenschr (1986) 0.77
[The effect of atrial natriuretic peptide on glucose tolerance and insulin level]. Med Klin (Munich) (1990) 0.77
Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus. Klin Wochenschr (1991) 0.77
The role of adrenal medulla in endogenous dopaminergic inhibition of aldosterone secretion. Res Exp Med (Berl) (1986) 0.76
[Comparison of ischemic pain threshold and reactive hyperemia in autonomic diabetic neuropathy and silent myocardial ischemia]. Z Kardiol (1991) 0.76
Thyrotoxic effect of high iodine doses on xenotransplanted autoimmune thyroid tissue in athymic nude mice. Acta Endocrinol Suppl (Copenh) (1987) 0.76
Re-evaluation of eye muscle autoantibody determination in Graves' ophthalmopathy: failure to detect a specific antigen by use of enzyme-linked immunosorbent assay, indirect immunofluorescence, and immunoblotting techniques. Acta Endocrinol (Copenh) (1989) 0.76
Circadian patterns of salivary melatonin and urinary 6-sulfatoxymelatonin before and after a 9 hour time-shift. Adv Exp Med Biol (1991) 0.76
Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers. Clin Pharmacol Ther (2000) 0.76
The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens (1991) 0.76
Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study. Arzneimittelforschung (1993) 0.76
Short-term effects on patient satisfaction of continuous glucose monitoring with the GlucoDay with real-time and retrospective access to glucose values: a crossover study. Diabetes Technol Ther (2009) 0.76
Somatic pain threshold and reactive hyperemia in autonomic diabetic neuropathy and silent myocardial ischemia. Int J Cardiol (1993) 0.75
Pituitary-adrenocortical function in treated Hodgkin disease. Lancet (1990) 0.75
[Effectiveness and efficacy of ambulatory diabetes patient education]. Dtsch Med Wochenschr (2000) 0.75
Pharmacodynamic effects of orally administered dexlipotam on endothelial function in type 2-diabetic patients. Int J Clin Pharmacol Ther (2007) 0.75
Thyroid hormone binding inhibition in critically ill patients--who is the inhibitor? Exp Clin Endocrinol (1990) 0.75
Stones and lithotripsy. Lancet (1993) 0.75